期刊文献+

术中放疗、术后全乳放疗在早期乳腺癌保乳治疗中的意义 被引量:6

Significance of intraoperative radiotherapy and postoperative whole-breast radiotherapy in breast-conserving therapy for early breast cancer
下载PDF
导出
摘要 目的:探讨术中放疗(intraoperative radiotherapy,IORT)、术后全乳腺放疗(whole-breast radiotherapy,WBRT)在早期乳腺癌保乳治疗中的意义。方法:选择有保乳意愿、原发灶直径≤40 mm的T1-2N0-1M0期乳腺癌患者149例,按放疗方式分为术中放疗组(n=52)、术中放疗+全乳放疗组(n=43)和全乳放疗组(n=54)。保乳手术予肿瘤外5~10 mm扩大切除,对明确的前哨淋巴结予以活检术和(或)腋窝淋巴结进行清扫处理。IORT剂量15.0~21.0 GY,中位剂量18.0 GY。WBRT剂量50.0 GY/25次。结果:术中放疗组、术中放疗+全乳放疗组与术后全乳放疗组5年生存率分别为100.0%、94.4%、100.0%(χ^2=2.40,P=0.301);5年局部控制率分别为100.0%、100.0%、94.9%(χ^2=3.17,P=0.142);5年无远转生存率分别为100.0%、82.2%、86.0%(χ^2=7.59,P=0.022)。Cox多因素分析提示,T分期是影响患者预后的临床因素(χ^2=4.71,P=0.030)。术中放疗+全乳放疗组皮肤、脂肪坏死发生率为9.3%(4/43),仅术中放疗组未出现肺组织晚反应放射性损伤。结论:对原发灶直径≤40 mm的T1-2N0-1M0期保乳患者采用IORT,在局部控制率、并发症方面均显示出明显优势,可以替代WBRT。但不建议采用术中放疗联合术后全乳腺照射的治疗策略。 Objective:To explore the significance of intraoperative radiotherapy(IORT)and postoperative whole-breast radiotherapy(WBRT)in breast-conserving therapy for early breast cancer.Methods:A total of 149 patients with T1-2N0-1M0 breast cancer who had the intention to preserve breast,and whose primary lesion diameter≤40 mm were selected.All patients were divided into three groups by postoperative radiotherapy type:52 cases were treated with IORT(IORT group),43 cases were treated with IORT+WBRT(IORT+WBRT group),and 54 cases were treated with WBRT(WBRT group).Breast-conserving therapy was performed for extended resection in the range of 5-10 mm of the tumor,with biopsy of confirmed sentinel lymph nodes and(or)dissection of axillary lymph nodes.The IORT ranged between 15.0 and 21.0 GY,with a median of 18.0 GY.WBRT with a total dose of 50.0 GY/25 fractions.Results:The 5-year survival rate of the IORT group,IORT+WBRT group and WBRT group was 100.0%,94.4% and 100.0%,respectively(χ^2=2.40,P=0.301).The 5-year local control rate was 100.0%,100.0% and 94.9%,respectively(χ^2=3.17,P=0.142).The no distant metastatic survival rate was 100.0%,82.2% and 86.0%,respectively(χ^2=7.59,P=0.022).Cox multivariate analysis showed that T stage was a significant clinical factor affecting the prognosis of patients(χ^2=4.71,P=0.030).Severe skin disease and fat necrosis were occurred in the IORT+WBRT group,with incidence of 9.3%(4/43).No late radiation damage in the lung tissue was observed in the IORT group.Conclusion:IORT has advantages in local control rate and complications for patients with T1-2N0-1M0 breast cancer and primary lesions diameter≤40 mm.The treatment strategy of IORT combined with postoperative WBRT is not recommended.
作者 田种泽 于洋 李莎 朱向辉 任正华 张超 傅华 TIAN Zhongze;YU Yang;LI Sha;ZHU Xianghui;REN Zhenghua;ZHANG Chao;FU Hua(Department of Radiation Oncology,the 940th Hospital of Joint Logistic Support Force of PLA,Lanzhou 730050,China)
出处 《西北国防医学杂志》 CAS 2020年第7期427-433,共7页 Medical Journal of National Defending Forces in Northwest China
基金 甘肃省自然科学基金资助项目(1606RJZA170)。
关键词 乳腺癌 保乳治疗 术中放疗 放射治疗 预后 并发症 breast cancer breast-conserving therapy intraoperative radiotherapy radiotherapy prognosis complications
  • 相关文献

参考文献3

二级参考文献32

  • 1Clarke M, Collins R, Darhy S, et al. Effects of radiotherapy and of differences in the exlent of surgery for early breast cancer on local reeurrence and 15-year survival: an overview of the randomized trial[J]. Lancet, 2005, 366(9503):2087-2106.
  • 2Reintgen C, Reintgen D, Solin LJ. Advances in local-regional treatment for patients with early-stage breast cancer: a review of the field[J]. Clin Breast Cancer, 2010, 10(3):180-187.
  • 3Vaidya JS, Tobias JS, Baum M, et at. Intraoperative radiotherapy for breast cancer[J]. Lancet Oncol, 2004, 5(3): 165-173.
  • 4Vaidya JS, Joseph DJ, Tobias JS, el al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non- inferiority phase 3 trial[J]. Lancet, 2010, 376(9735):91-102.
  • 5Osti MF, Carnevale A, Bracci S, et al. Exclusive electron intraoperative radiotherapy in early-stage breast cancer: a monoinstitulional experience[J]. Anticancer Res, 2013, 33(3):1229- 1235.
  • 6Stmad V, Hildebrandt G, Petter R, et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multieenter phase II trial using interstitial multieatheter braehytherapy alone after breast-conserving surgery[J].lnt J Radiat Oncol Biol Phys, 2011, 80(1):17-24.
  • 7Belkacdmi Y, Chauvet MP, Giard S, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase 11 study[J]. Radiother Oneol, 2009, 90(1):23-29.
  • 8Chen PY, Wallace M, Mitchell C, et ah Four-year efficacy, cosmesis, and toxicity using three-dimensional eonformal external beam radiation therapy to deliver accelerated partial breast irradiation[J]. Int J Radiat Oneol Biol Phys, 2010, 76(4):991-997.
  • 9Vieini F, Winter K, Wong J, et at. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT)confined to the region of the lumpectomy cavity for stage I/ll breast carcinoma[J]. Int J Radiat Oncol Biol Phys, 2010, 77(4): 1120-1127.
  • 10Belletti B, Vaidya JS, D'Andrea S, et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding[J]. Clin Cancer Res, 2008, 14(5): 1325-1332.

共引文献21

同被引文献96

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部